Cargando…
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
Background: Oxysterol relationship with cardiovascular (CV) risk factors is poorly explored, especially in moderately hypercholesterolaemic subjects. Moreover, the impact of nutraceuticals controlling hypercholesterolaemia on plasma levels of 24-, 25- and 27-hydroxycholesterol (24-OHC, 25-OHC, 27-OH...
Autores principales: | Cicolari, Stefania, Pavanello, Chiara, Olmastroni, Elena, Puppo, Marina Del, Bertolotti, Marco, Mombelli, Giuliana, Catapano, Alberico L., Calabresi, Laura, Magni, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911956/ https://www.ncbi.nlm.nih.gov/pubmed/33525601 http://dx.doi.org/10.3390/nu13020427 |
Ejemplares similares
-
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
por: Ruscica, Massimiliano, et al.
Publicado: (2019) -
Correction to: Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
por: Ruscica, Massimiliano, et al.
Publicado: (2019) -
Effect of repeated oral administration of Bifidobacterium longum BB536 on
apomorphine-induced rearing behavior in mice
por: ORIKASA, Shuzo, et al.
Publicado: (2016) -
Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial
por: Takeda, Tsutomu, et al.
Publicado: (2023) -
Protective effect of Bifidobacterium longum BB536 against nausea caused by pirfenidone in a mouse model of pellagra
por: KURONUMA, Koji, et al.
Publicado: (2023)